ACAT NP Life Sciences Health Industry Group Inc.
Services-Educational Services · OTC · SEC CIK 1781726 · Fiscal year ends 12/31
Financial factors as of 2023-12-31 (2023Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY202.8%
TTM EPS YoY—
Revenue 3-yr CAGR112.8%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-0.5%
Net margin13.4%
FCF margin—
EBITDA margin—
Returns
ROE108.6%
ROA19.0%
ROIC (approx.)—
Asset turnover1.41x
Leverage & solvency
Liabilities / assets78.7%
Debt / equity0.00x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income-3.80x
Accruals ratio90.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 | FY20202020-12-31 | FY20192019-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $144,599 | $102,002 | $34,992 | $15,000 | $43,000 |
| SG&A expense | $165,311 | $120,857 | $100,673 | $146,091 | $151,859 |
| Operating income | -$690 | -$18,855 | -$65,681 | -$131,091 | -$108,859 |
| Interest expense | $645 | $1 | — | — | — |
| Pretax income | -$1,335 | -$18,856 | -$65,677 | -$131,065 | -$108,827 |
| Income tax | $1,600 | — | — | — | — |
| Net income | -$2,935 | -$18,856 | -$65,677 | -$131,065 | -$108,827 |
| EPS (basic) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS (diluted) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted avg. shares (diluted) | 42.96M | 42.96M | 42.96M | 42.96M | 34.12M |
| Banking | |||||
| Net interest income | — | -$1 | $4 | — | — |
| Balance sheet | |||||
| Cash & equivalents | $70,614 | $121,859 | $27,986 | $118,611 | $242,933 |
| Intangibles | — | — | — | — | $7,164 |
| Total assets | $76,864 | $127,784 | $38,411 | $118,611 | $250,097 |
| Current liabilities | $38,121 | $108,468 | — | — | — |
| Total liabilities | $60,483 | $108,468 | $239 | $14,762 | $15,183 |
| Shareholders' equity | $16,381 | $19,316 | $38,172 | $103,849 | $234,914 |
| Shares outstanding | 42.96M | 42.96M | 42.96M | 42.96M | 42.96M |
| Cash flow statement | |||||
| Operating cash flow | -$73,607 | $93,873 | -$90,625 | -$124,322 | -$4,266 |
| Investing cash flow | — | — | — | — | -$8,600 |
| Financing cash flow | $22,362 | — | — | — | $364,426 |
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.